Nonanoylcarnitine

Nonanoylcarnitine is a metabolite associated with chronic environmental exposure to polycyclic aromatic hydrocarbons (PAH) and fragmented QRS waves in acute myocardial infarction. Nonanoylcarnitine can be used as a potential biomarker for the metabolic outcome of PAH exposure and the prognosis of acute myocardial infarction[1][2].

Product Specifications

CAS Number

[151109-67-0]

Product Name Alternative

C9 carnitine

UNSPSC

12352211

Target

Endogenous Metabolite

Type

Natural Products

Related Pathways

Metabolic Enzyme/Protease

Field of Research

Cancer; Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/nonanoylcarnitine.html

Purity

99.94

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

CCCCCCCCC(O[C@H](CC([O-])=O)C[N+](C)(C)C)=O

Molecular Formula

C16H31NO4

Molecular Weight

301.42

References & Citations

[1]Wang Z, et al. Human metabolic responses to chronic environmental polycyclic aromatic hydrocarbon exposure by a metabolomic approach. J Proteome Res. 2015 Jun 5;14 (6) :2583-93.|[2]Li J, et al. Metabolomics Study Revealing the Potential Risk and Predictive Value of Fragmented QRS for Acute Myocardial Infarction. J Proteome Res. 2020 Aug 7;19 (8) :3386-3395.